123 related articles for article (PubMed ID: 26261818)
1. Study of C-MYC amplification and expression in Iranian gastric cancer samples using CISH and IHC methods.
Khaleghian M; Jahanzad I; Shakoori A; Ardalan FA; Azimi C
Adv Biomed Res; 2015; 4():116. PubMed ID: 26261818
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Amplification and Expression of the C-MYC Gene with Survival among Gastric Cancer Patients.
Khaleghian M; Shakoori A; Razavi AE; Azimi C
Asian Pac J Cancer Prev; 2015; 16(16):7061-9. PubMed ID: 26514491
[TBL] [Abstract][Full Text] [Related]
3. Association Between Amplification and Expression of C-MYC Gene and Clinicopathological Characteristics of Stomach Cancer.
Khaleghian M; Jahanzad I; Shakoori A; Emami Razavi A; Azimi C
Iran Red Crescent Med J; 2016 Feb; 18(2):e21221. PubMed ID: 27175302
[TBL] [Abstract][Full Text] [Related]
4. [Comparision of HER2/neu oncogene detected by chromogenic in-situ hybridization and immunohistochemistry in breast cancer].
Zhang GH; Shi DR; Liang XM; Hou JH; Kang SY; Zhu WD; Li XB; Shao Y; Chen LR; Zhou Y
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):580-3. PubMed ID: 17134562
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of HER2 gene amplification and its protein expression in 165 cases of breast carcinoma: comparison of chromogenic in-situ hybridization and immunohistochemistry].
Shen DH; Wang FH; Yu YZ
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):457-60. PubMed ID: 17845758
[TBL] [Abstract][Full Text] [Related]
6. Chromogenic
Ali AHM; Yahya AQ; Mohammed HL
Open Access Maced J Med Sci; 2019 Jun; 7(12):1917-1925. PubMed ID: 31406529
[TBL] [Abstract][Full Text] [Related]
7. Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status.
Madrid MA; Lo RW
Breast Cancer Res; 2004; 6(5):R593-600. PubMed ID: 15318940
[TBL] [Abstract][Full Text] [Related]
8. Chromogenic In Situ Hybridisation Test for Breast Cancer Patients with Equivocal IHC Results--a Study from Iran.
Mehrazma M; Kalantari E; Rezvani H; Bahar B; Basi A; Razavi SM; Rakhshani N
Asian Pac J Cancer Prev; 2015; 16(17):7695-700. PubMed ID: 26625783
[TBL] [Abstract][Full Text] [Related]
9. Predicting Effects of Clinicopathological Variables on
Hashemi Bahremani M; Ebrahimi A; Fallahi M
Iran J Pathol; 2020; 15(3):217-224. PubMed ID: 32754217
[TBL] [Abstract][Full Text] [Related]
10. Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH).
Fischer I; de la Cruz C; Rivera AL; Aldape K
Diagn Mol Pathol; 2008 Dec; 17(4):227-30. PubMed ID: 18382350
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray.
Rakhshani N; Kalantari E; Bakhti H; Sohrabi MR; Mehrazma M
Asian Pac J Cancer Prev; 2014; 15(18):7597-602. PubMed ID: 25292034
[TBL] [Abstract][Full Text] [Related]
12. Her2 amplification: correlation of chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization.
Wixom CR; Albers EA; Weidner N
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):248-51. PubMed ID: 15551739
[TBL] [Abstract][Full Text] [Related]
13. Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).
Kiyose S; Igarashi H; Nagura K; Kamo T; Kawane K; Mori H; Ozawa T; Maeda M; Konno K; Hoshino H; Konno H; Ogura H; Shinmura K; Hattori N; Sugimura H
Pathol Int; 2012 Nov; 62(11):728-34. PubMed ID: 23121603
[TBL] [Abstract][Full Text] [Related]
14. Evaluating
Atabati H; Raoofi A; Amini A; Farahani RM
Open Access Maced J Med Sci; 2018 Nov; 6(11):1977-1981. PubMed ID: 30559846
[TBL] [Abstract][Full Text] [Related]
15. The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer.
Hyun CL; Lee HE; Kim KS; Kim SW; Kim JH; Choe G; Park SY
J Clin Pathol; 2008 Mar; 61(3):317-21. PubMed ID: 17761736
[TBL] [Abstract][Full Text] [Related]
16. Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.
Bilous M; Morey A; Armes J; Cummings M; Francis G
Pathology; 2006 Apr; 38(2):120-4. PubMed ID: 16581651
[TBL] [Abstract][Full Text] [Related]
17. EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study.
Bernardes VF; Gleber-Netto FO; Sousa SF; Rocha RM; Aguiar MC
BMJ Open; 2013 Jan; 3(1):. PubMed ID: 23358562
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of HER2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer.
Todorović-Raković N; Jovanović D; Nesković-Konstantinović Z; Nikolić-Vukosavljević D
Exp Mol Pathol; 2007 Jun; 82(3):262-8. PubMed ID: 17335803
[TBL] [Abstract][Full Text] [Related]
19. MYC amplification is associated with poor survival in small cell lung cancer: a chromogenic in situ hybridization study.
Alves Rde C; Meurer RT; Roehe AV
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2021-5. PubMed ID: 25012251
[TBL] [Abstract][Full Text] [Related]
20. Identification of MYCN gene amplification in neuroblastoma using chromogenic in situ hybridization (CISH): an alternative and practical method.
Bhargava R; Oppenheimer O; Gerald W; Jhanwar SC; Chen B
Diagn Mol Pathol; 2005 Jun; 14(2):72-6. PubMed ID: 15905689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]